Rate of MetS Unchanged after One Year of GH Replacement

Slideshow

Results of a new study highlight the importance of intensive treatment of all comorbidities associated with adult growth hormone deficiency.

Related Videos
Related Content
Stock imagery of diabetes related items. | Credit: Fotolia

ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Elena Christofides, MD | Credit: Endocrinology Associates

Insulin Glargine Biosimilar Demonstrates Bioequivalence to Originator for Type 2 Diabetes

April 13th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
Endocrinology Month in Review: March 2024 thumbnail featuring HCOLive endocrinology logo

Endocrinology Month in Review: March 2024

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.